Topography, Clinical, and Genomic Correlates of 5q Myeloid Malignancies Revisited

Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.36.1824
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Myeloid Leukemia With T(7;21)(p22;q22) and 5q Deletion

Oncology Reports
MedicineCancer ResearchOncology
2013English

Driver Mutation‐Specific Clinical and Genomic Correlates Differ Between Primary and Secondary Myelofibrosis

American Journal of Hematology
Hematology
2019English

Role of the Microenvironment in Myeloid Malignancies

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2017English

Clinical Experience With the BCL2-inhibitor Venetoclax in Combination Therapy for Relapsed and Refractory Acute Myeloid Leukemia and Related Myeloid Malignancies

American Journal of Hematology
Hematology
2017English

Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells

Frontiers in Oncology
Cancer ResearchOncology
2015English

Community-Acquired Infections and Their Association With Myeloid Malignancies

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2014English

New Acute Myeloid Leukemia-Derived Cell Line: MUTZ-8 With 5q−

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

T(3;8)(q21;q24) in Myeloid Malignancies

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

BCL-2 Inhibition: Stemming the Tide of Myeloid Malignancies

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy